Cholesterol-lowering therapy may retard the progression of diabetic nephropathy - Response

被引：0
|
作者：
Lam, KSL
机构：
来源：
DIABETOLOGIA | 1996年 / 39卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：368 / 368
页数：1
相关论文
共 50 条
  • [21] Biomedicine - Cholesterol-lowering drugs may boost bones
    Vogel, G
    SCIENCE, 1999, 286 (5446) : 1825 - 1826
  • [22] New molecular targets for cholesterol-lowering therapy
    Izzat, NN
    Deshazer, ME
    Loose-Mitchell, DS
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 293 (02): : 315 - 320
  • [23] Statine: The cholesterol-lowering therapy of the Alzheimer dementia
    Schulz, Jorg B.
    NERVENARZT, 2007, 78 : 153 - 154
  • [24] Statin trials and goals of cholesterol-lowering therapy
    Grundy, SM
    CIRCULATION, 1998, 97 (15) : 1436 - 1439
  • [25] Cardiovascular Benefits of Aggressive Cholesterol-Lowering Therapy
    Clearfield, Michael B.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2011, 111 (04):
  • [26] Reply to: "Appropriate use of cholesterol-lowering therapy"
    Langsted, Anne
    Freiberg, Jacob J.
    Nordestgaard, Borge G.
    ATHEROSCLEROSIS, 2017, 262 : 200 - 201
  • [27] Effect of cholesterol-lowering therapy on endothelial function
    Houghton, JL
    CIRCULATION, 2001, 104 (02) : E6 - E6
  • [28] 'Typical' MI survivors may benefit from cholesterol-lowering therapy, say researchers
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (22) : 2686 - 2686
  • [29] Cholesterol-lowering gene therapy prevents HFpEF in obese type 2 diabetic mice
    Aboumsallem, J. P.
    Muthuramu, I.
    Mishra, M.
    De Geest, B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 165 - 165
  • [30] Cholesterol-lowering drugs may not prevent Alzheimer's disease
    不详
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2008, 23 (04): : 396 - 397
12345